Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 19, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $145.00 to $4,138,406.10.

Highlighted Stocks Traded by Insiders:

Gevo (GEVO) - FREE Research Report

Lund Brett, who is EVP, GC and Secretary at Gevo, sold 4,717 shares at $0.26 on Feb. 19, 2015. Following this transaction, the EVP, GC and Secretary owned 71,543 shares meaning that the stake was reduced by 6.19% with the 4,717-share transaction.

The shares most recently traded at $0.27, up $0.01, or 2.78% since the insider transaction. Historical insider transactions for Gevo go as follows:

  • 4-Week # shares bought: 181,484
  • 4-Week # shares sold: 4,727
  • 12-Week # shares bought: 181,484
  • 12-Week # shares sold: 49,690
  • 24-Week # shares bought: 181,484
  • 24-Week # shares sold: 97,936

The average volume for Gevo has been 2.9 million shares per day over the past 30 days. Gevo has a market cap of $24.1 million and is part of the basic materials sector and chemicals industry. Shares are down 26.56% year-to-date as of the close of trading on Thursday.

Gevo, Inc., a renewable chemicals and biofuels company, focuses primarily on the production and sale of isobutanol and related products from renewable feedstocks. Currently, there are 2 analysts who rate Gevo a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GEVO - FREE

TheStreet Quant Ratings rates Gevo as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full Gevo Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cheniere Energy (LNG) - FREE Research Report

Teague R Keith, who is Executive VP - Asset Group at Cheniere Energy, sold 25,000 shares at $76.23 on Feb. 19, 2015. Following this transaction, the Executive VP - Asset Group owned 712,221 shares meaning that the stake was reduced by 3.39% with the 25,000-share transaction.

Rayford Greg W., who is Sr. VP and General Counsel at Cheniere Energy, sold 12,000 shares at $74.72 on Feb. 19, 2015. Following this transaction, the Sr. VP and General Counsel owned 716,964 shares meaning that the stake was reduced by 1.65% with the 12,000-share transaction.

The shares most recently traded at $73.92, down $0.80, or 1.08% since the insider transaction. Historical insider transactions for Cheniere Energy go as follows:

  • 4-Week # shares sold: 87,000
  • 12-Week # shares sold: 159,750
  • 24-Week # shares sold: 810,750

The average volume for Cheniere Energy has been 3.4 million shares per day over the past 30 days. Cheniere Energy has a market cap of $17.9 billion and is part of the basic materials sector and energy industry. Shares are up 7.32% year-to-date as of the close of trading on Thursday.

Cheniere Energy, Inc., an energy company, is engaged in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business. Currently, there are 3 analysts who rate Cheniere Energy a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNG - FREE

TheStreet Quant Ratings rates Cheniere Energy as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Cheniere Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 1,333 shares at $7.41 on Feb. 19, 2015. Following this transaction, the Executive Chairman owned 1.1 million shares meaning that the stake was boosted by 0.12% with the 1,333-share transaction.

The shares most recently traded at $7.18, down $0.23, or 3.21% since the insider transaction.

The average volume for Tiptree Financial has been 20,000 shares per day over the past 30 days. Tiptree Financial has a market cap of $230.8 million and is part of the financial sector and insurance industry. Shares are down 10.49% year-to-date as of the close of trading on Thursday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings rates Tiptree Financial as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, generally high debt management risk and weak operating cash flow. Get the full Tiptree Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null